World's Best Scientists 2026 revealed!
Franca Fagioli

Franca Fagioli

D-Index & Metrics

Medicine

D-Index
76
Citations
23033
World Ranking
18730
National Ranking
754

Overview

Franca Fagioli is affiliated with the University of Turin in Italy and has contributed extensively to research in the field of medicine, with a particular focus on hematology, pediatrics, public health, pulmonary medicine, and oncology. Their work spans several key subfields including hematology, pediatrics, perinatology, child health, public health, environmental and occupational health, pulmonary and respiratory medicine, and oncology.

The scientist's research covers multiple important topics, notably:

  • Childhood Cancer Survivors' Quality of Life
  • Hematopoietic Stem Cell Transplantation
  • Acute Lymphoblastic Leukemia research
  • Sarcoma Diagnosis and Treatment
  • Acute Myeloid Leukemia Research
  • Lymphoma Diagnosis and Treatment
  • Neuroblastoma Research and Treatments

Franca Fagioli has published in several frequent venues, indicating a strong presence in journals related to hematology and oncology, including:

  • Blood
  • Bone Marrow Transplantation
  • Journal of Clinical Oncology
  • Pediatric Blood & Cancer
  • Cancers

Among recent notable papers associated with Fagioli's research circle or thematic interests are:

  • "Soft tissue and visceral sarcomas: ESMO-EURACAN-GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up," 2021, Annals of Oncology
  • "Emapalumab in Children with Primary Hemophagocytic Lymphohistiocytosis," 2020, New England Journal of Medicine
  • "Bone sarcomas: ESMO-EURACAN-GENTURIS-ERN PaedCan Clinical Practice Guideline for diagnosis, treatment and follow-up," 2021, Annals of Oncology
  • "NTRK Fusions in Central Nervous System Tumors: A Rare, but Worthy Target," 2020, International Journal of Molecular Sciences
  • "A multi-target lateral flow immunoassay enabling the specific and sensitive detection of total antibodies to SARS COV-2," 2020, Talanta

Frequent collaborators in their research include Franco Locatelli, Paola Quarello, Marco Zecca, Giulia Zucchetti, and Francesco Saglio, reflecting ongoing partnerships that support work in hematology and oncology disciplines.

Best Publications

  • Extensive Amplification and Self-Renewal of Human Primitive Hematopoietic Stem Cells From Cord Blood

    Wanda Piacibello;Fiorella Sanavio;Lucia Garetto;Antonella Severino

  • Bone sarcomas: ESMO-PaedCan-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up

    P.G. Casali;S. Bielack;N. Abecassis;H.T. Aro

  • Factors associated with outcomes of unrelated cord blood transplant: Guidelines for donor choice

    Eliane Gluckman;Vanderson Rocha;William Arcese;Gérard Michel

  • Emapalumab in Children with Primary Hemophagocytic Lymphohistiocytosis

    Franco Locatelli;Michael B. Jordan;Carl Allen;Simone Cesaro

  • Isolation of human mesenchymal stem cells: bone marrow versus umbilical cord blood.

    Katia Mareschi;Eleonora Biasin;Wanda Piacibello;Massimo Aglietta

  • Engraftment in nonobese diabetic severe combined immunodeficient mice of human CD34(+) cord blood cells after ex vivo expansion: evidence for the amplification and self-renewal of repopulating stem cells.

    Wanda Piacibello;Fiorella Sanavio;Antonella Severino;Alessandra Danè

  • Mesenchymal stem cell transplantation in amyotrophic lateral sclerosis: A Phase I clinical trial

    L. Mazzini;I. Ferrero;I. Ferrero;V. Luparello;D. Rustichelli

  • Expansion of Mesenchymal Stem Cells Isolated From Pediatric and Adult Donor Bone Marrow

    Katia Mareschi;Ivana Ferrero;Deborah Rustichelli;Simona Aschero

  • Human mesenchymal stem cell transplantation extends survival, improves motor performance and decreases neuroinflammation in mouse model of amyotrophic lateral sclerosis.

    Alessandro Vercelli;Alessandro Vercelli;Om Mereuta;Om Mereuta;Diego Garbossa;Diego Garbossa;G Muraca;G Muraca

  • Human mesenchymal stem cells as a two-edged sword in hepatic regenerative medicine: engraftment and hepatocyte differentiation versus profibrogenic potential

    L Valfrè di Bonzo;I Ferrero;C Cravanzola;K Mareschi

  • A phase II trial of sorafenib in relapsed and unresectable high-grade osteosarcoma after failure of standard multimodal therapy: an Italian Sarcoma Group study

    G Grignani;Emanuela Palmerini;P. Dileo;S. D. Asaftei

  • Postrelapse Survival in Osteosarcoma of the Extremities: Prognostic Factors for Long-Term Survival

    Stefano Ferrari;Antonio Briccoli;Mario Mercuri;Franco Bertoni

  • Stem cell therapy in amyotrophic lateral sclerosis: a methodological approach in humans

    Letizia Mazzini;Franca Fagioli;Riccardo Boccaletti;Katia Mareschi

  • Sorafenib and everolimus for patients with unresectable high-grade osteosarcoma progressing after standard treatment: a non-randomised phase 2 clinical trial

    Giovanni Grignani;Emanuela Palmerini;Virginia Ferraresi;Lorenzo D'Ambrosio

  • Stem cell treatment in Amyotrophic Lateral Sclerosis.

    Letizia Mazzini;Katia Mareschi;Ivana Ferrero;Elena Vassallo

  • Response to Rituximab-Based Therapy and Risk Factor Analysis in Epstein Barr Virus–Related Lymphoproliferative Disorder After Hematopoietic Stem Cell Transplant in Children and Adults: A Study From the Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation

    Jan Styczynski;Lidia Gil;Gloria Tridello;Per Ljungman;Per Ljungman

  • Chronic graft-versus-host disease in children: incidence, risk factors, and impact on outcome.

    Marco Zecca;Arcangelo Prete;Roberto Rondelli;Edoardo Lanino

  • Mesenchymal stromal cell transplantation in amyotrophic lateral sclerosis: a long-term safety study.

    Letizia Mazzini;Katia Mareschi;Katia Mareschi;Ivana Ferrero;Ivana Ferrero;Massimo Miglioretti

  • Autologous mesenchymal stem cells: clinical applications in amyotrophic lateral sclerosis

    Letizia Mazzini;Katia Mareschi;Ivana Ferrero;Elena Vassallo

  • Bone sarcomas: ESMO-PaedCan-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up

    P.G. Casali;S. Bielack;N. Abecassis;H.T. Aro

Frequent Co-Authors

Marco Zecca
Marco Zecca University of Pavia
Andrea Pession
Andrea Pession University of Bologna
Massimo Aglietta
Massimo Aglietta University of Turin
Giuseppe Basso
Giuseppe Basso University of Padua
Piero Picci
Piero Picci University of Bologna
Andrea Biondi
Andrea Biondi University of Milano-Bicocca
Francesco Locatelli
Francesco Locatelli University of Pavia
Stefano Ferrari
Stefano Ferrari Veneto Eye Bank Foundation
Alice Bertaina
Alice Bertaina Stanford University
Alessandro Vercelli
Alessandro Vercelli University of Turin

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Medicine in the USA offers varied educational routes, especially for those seeking flexible or alternative healthcare careers. LPN online programs provide a fast-track option to become a Licensed Practical Nurse, appealing to those who want to enter the workforce quickly.

If your interest is in mental health, online pmhnp programs allow registered nurses to specialize as Psychiatric Mental Health Nurse Practitioners. These programs balance clinical experience with online coursework, opening doors to advanced practice roles.

For students seeking non-clinical paths, an affordable healthcare administration degree online prepares graduates to manage healthcare facilities or systems efficiently. This is ideal for those interested in leadership and organizational roles.

For further advancement, consider the cheapest mha programs online healthcare which offer master’s-level training without the heavy financial burden. These accredited courses equip you with skills for upper-level management positions in the growing healthcare industry.

Best Scientists Citing Franca Fagioli

Trending Scientists